Preventie van infecties na open chirurgische ingrepe
- Conditions
- Post-operative infectionSurgical site infectionPneumoniaSepsis
- Registration Number
- NL-OMON25596
- Lead Sponsor
- Radboud university medical center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 104
Inclusion Criteria
Willing and able to provide written informed consent.
No acute infection at the time of vaccination or surgery (defined as fever above 38.5 ¢XC).
Exclusion Criteria
Immunosuppressed status, due to medication or otherwise.
Corticosteroid or other immunosuppressive treatment, including general radiation. Inhaled steroids are not a contra-indication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main study outcome is the assessment of immune cell function after BCG vaccination and after surgery
- Secondary Outcome Measures
Name Time Method Secondary outcomes are the occurrence of SSI, pneumonia, sepsis, UTI, ileus